Teva Pharmaceutical Industries Ltd. announced that it has signed a definitive agreement with Allergan plc to acquire Allergan Generics in...
Teva Pharmaceutical Industries has announced that it has received regulatory approval from the European Commission for its acquisition of Allergan...
Teva Pharmaceutical Industries Ltd. announced a proposal to acquire all of the outstanding shares of Mylan N.V. in a transaction...
The FDA had reached a final decision to fully withdraw approval of preterm-birth drug Makena and its generics, a full 12 years after the treatment appeared on the market.
Merck Inc., announced that the company has entered into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generics manufacturers.
The FDA has announced that it has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules) from Eli Lilly,...
The EMA's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing...
-Otsuka has finally lost its battle with the FDA to prevent generics of its Abilify (aripiprazole) from entering the market....
AstraZeneca has filed a citizen petition with the FDA arguing that the FDA cannot approve more generics because it granted...
Novartis announced its intention to separate Sandoz, its generics and biosimilars division into a new publicly traded standalone company, by way of a 100% spin-off